Mathematical modelling of immune regulation of type 1 diabetes

BioSystems

Volumn 102, Issue 2-3, 2010, Pages 88-98

  Magombedze, Gesham ^a,b   Nduru, Polite ^a   Bhunu, Claver P ^a   Mushayabasa, Steady ^a  

^a NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Zimbabwe)

^b AFRICAN INSTITUTE FOR MATHEMATICAL SCIENCES   (South Africa)

Author keywords

Autolytic T cells; Immune regulation; Mathematical modelling; Type 1 diabetes

Indexed keywords

CELL ORGANELLE; DIABETES; IMMUNE RESPONSE; NUMERICAL MODEL;

ARTICLE; CELL FUNCTION; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; MATHEMATICAL MODEL; PANCREAS ISLET CELL; REGULATORY T LYMPHOCYTE; SIMULATION;

EID: 78049527330     PISSN: 03032647     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biosystems.2010.07.018     Document Type: Article

References (34)

1. Alyanakian M., You S., Damotte D., Gouarin C., Esling A. Diversity of regulatory CD4+ T cells controlling distinct organ specific autoimmune diseases. PNAS 2003, 100:15806-15811.
2. Barclay, L., 2005. Type 1 diabetes. New Medical Therapy: NMT BRIEFS, 2005. THOMSON CENTERWATCH, http://www.centerwatch.com/.
3. Bergerot I., Arreaza G.A., Cameron M.J., Burdick M.D., Strieter R.M. Insulin B-chain reactive CD4+ regulatory T-cells induced oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells. Diabetes 1999, 48:1720-1729.
4. 0 and its role on global stability. IMA 2002, 125:229-250.
5. Chen W., Herold K.C., Bluestone J.A. Achieving antigen-specific tolerance in diabetes: regulating specifically. Int. Rev. Immunol. 2005, 24:287-305.
6. Chowdhury S.A., Nagata M., Yamada K. Tolerance mechanisms in murine autoimmune diabetes induced by anti-ICAM-1/LFA-1 mAb and anti CD8-mAb. J. Med. Sci. 2002, 48(6):167-175.
7. de Figueiredo L.F., Schuster S., Kaleta C., Fell D.A. Can sugars be produced from fatty acids? A test case for pathway analysis tools. Bioinformatics 2009, 25(1):152-158.
8. Dirk H., Matthias von H. Regulatory T cells and type 1 diabetes: A short Analytical Review. Clin. Immunol. 2004, 112(3):202-209.
9. Dotta F., Fondelli C., Di Mario U. Type 1 diabetes mellitus as a polygenic multifactorial disease: immunopathogenic mechanisms of beta-cell destruction. Acta Biomed. 2005, 76(3):14-18.
10. Eldor R., Cohen I.R., Raz I. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus. Int. Rev. Immunol. 2005, 24:327-339.
11. Filippi C., Bresson D., von Herrath M. Antigen-specific induction of regulatory T cells for type 1 diabetes therapy. Int. Rev. Immunol. 2005, 24:341-360.
12. Freiesleben De Blasio B., Pociot P.F., Karlsen A.E., Nerup J. Onset of type 1 diabetes: a dynamical instability. Diabetes 1999, 48:1677-1685.
13. Gillespie K.M. Type 1 diabetes: pathogenesis and prevention. CMAJ 2006, 175(2):165.
14. Goudy K.S., Tisch R. Immunotherapy for the prevention and treatment of type 1 diabetes. Int. Rev. Immunol. 2005, 24:307-326.
15. Irie J., Wu Y., Kachapati K., Mittler R.S., Ridgway W.M. Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes. Diabetes 2007, 56:186-196.7.
16. Janeway A.C., Travers P., Walport M., Shlomchik J.M. IMMUNO BIOLOGY: The Immune System in Health and Disease 2005, Garland Science Publishing.
17. Kanagawa O., Militech A., Vaupel B.A. Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic non obese diabetic mice. J. Immunol. 2002, 168:6159-6164.
18. Krishnamurthy B., Dudek N.L., McKenzie M.D., Purcell A.W., Brooks A.G., Gellert S., Colman P.G., Harrison L.C., Lew A.M., Thomas H.E., Kay T.W.H. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J. Clin. Invest. 2006, 116:3258-3265.
19. Kublik, R.A., 2005. Modelling the onset of type 1 diabetes. MSc Thesis. University of British Columbia, Canada.
20. Lee L., Xu B., Michie S.A., Beilhack F.G., Warganich T., Turley S. The role of TNF-α in the pathogenesis of type 1 diabetes in the non-obese diabetic mouse: analysis of dentritic cell maturation. PNAS 2005, 102(44):15995-16000.
21. Mar'ee A.F.M., Kublik R. Modelling the onset of type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease?. Philos. Trans. R. Soc. A 2006, 364:1267-1282.
22. Mauricio D., Mandrup-Poulsen T. Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 1998, 47:1537-1543.
23. Nagata M., Yokono Y., Hayakawa M., Kawase Y., Hatamori N., Ogawa W., Yonezawa K., Shii K., Baba S. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice. J. Immunol. 1989, 143(4):1155-1162.
24. Narendran P., Estella E., Fourlanos S. Immunology of type 1 diabetes. Q. J. Med. 2005, 98:547-556.
25. Nerup J., Platz P., Andersen O. HLA antigens and diabetes mellitus. Lancet 1974, 2:864-866.
26. Qiu Z., Yu J., Zou Y. The asymptotic behavior of a chemostat model. Disc. Cont. Dynam. Syst.-Ser. B 2004, 4(3):721-727.
27. Rabinovitch A. An update on cytokines in the pathogenesis of insulin diabetes mellitus. Diabetes Metab. Rev. 1998, 14:129-151.
28. Raz I., Elias D., Avron A., Tamir M., Metzger M., Cohen I.R. β-cell function in newonset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. The Lancet 2001, 358(9295):1749-1753.
29. Raz I., Eldor R., Naparstek Y. Immune modulation for prevention of type 1 diabetes mellitus. Trends Biotechnol. 2005, 23(3):128-134.
30. Thivolet C. Beta cells in type-1 diabetes: victims or activators of T cell response?. Diabetes Metab. (Paris) 2002, 28:267-269.
31. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996, 85:291-297.
32. Wang Y., Pontesilli O., Gill R.G., Rosa F.G.L., Lafferty K.J. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. PNAS 2004, 88:527-531.
33. Weinman E.O., Strisower E.H., Chaikoff I.L. Conversion of fatty acids to carbohydrate: application of isotopes to this problem and role of the Krebs cycle as a synthetic pathway. Physiol. Rev. 1957, 37:252-272.
34. Wigginton J.E., Kischner D. A model to predict cell mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J. Immunol. 2001, 166(3):1951.